Mike Lamson's professional experience includes planning and directing clinical pharmacology and clinical research activities and working with multifunctional study teams to design, deliver, and report NDA-ready documents. Strategic regulatory experience includes development of compounds following various regulatory pathways including the NDA, sNDA, ANDA, and the 505(b)2 routes of approval. Experience also includes using innovative analytical methods to evaluate in vivo drug delivery performance and to optimize doses, dosing regimens, and study designs throughout drug development.He has enjoyed the clinical drug development experience and working with his friends and colleagues in the RTP area for the past 10 years.